Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + Prednisone in Myelofibrosis
NCT00227591Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2005
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in myelofibrosis (MF), sponsored by National Cancer Institute. Started Dec 2005; status: completed.
02
Drugs
lenalidomide
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00227591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227591.